Jazz Pharmaceuticals
Large Cap · Healthcare · Biotechnology
$253.13+$4.77 (+1.92%)
Jazz Pharmaceuticals
Large Cap · Healthcare · Biotechnology
$253.13+$4.77 (+1.92%)
Stock analysis
Get the AI take on JAZZ
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$105.00
High$261.30
Today $253.13
RSI (14)
46.8Neutral
03070100
Overall score
59/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$196
Current price
$253.13
Median target
$285
Highest
$315
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- Price / FCF: Real cash coming through the door backs up what you're paying.
What to watch
- Debt exceeds cash by $2.2B, increasing balance-sheet pressure, a warning sign.
- ROE: Shareholders aren't seeing much return on the money tied up in this business.
What the market charges
Forward P/E
Favorable · 50% below avg
9.70x
Price / sales
Reasonable · Priced reasonably against its revenue
3.46x
Price / FCF
Strong · Priced well within what its cash flow supports
9.99x
EV / EBITDA
Strong · Operating earnings comfortably support this price
9.40x
How efficiently it compounds
ROIC
Strong · Comfortably clears the bar for efficient capital use
17.2%
ROE
Needs attention · Unfavorable
22.1%
Debt / equity
Middle ground · Mixed
0.92x
Current ratio
Strong · Comfortable room to cover bills due within a year
1.78x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $15.90B | 16.9 | +12.6% | 59 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |